1.Immunocytochemical evidence of the presence of CD4-Nef complexes on human T-cell surface enhancing CD4 down-regulation
Nianci GENG ; Fengyi YIN ; Juntang QIU ; Al ET ;
Chinese Journal of Infectious Diseases 1999;0(01):-
Objective This study aims to investigate the role of Nef or Vpu of HIV 1 in the process of CD4 down regulation. Methods After transfection/infection, the cells that constitutively express Nef or Vpu were then properly prepared for indirect pre or post embedding immunocytochemistry and for further semiquantitative analyses. Results The number of CD4 molecules on the cell surface and in the cytoplasm of Vpu + cells was less than those in Vpu - cells. The number of CD4 molecules on the cell surface of Nef + Jurkat and HPBALL cells was less than that on the Nef - cell membranes. While CD4 molecules in the cytoplasm of Nef - Jurkat and HPBALL cells were less than those in the cytoplasm of Nef + cells. That Vpu partially co localized with Gag was analyzed by confocal microscopy; however, no CD4 Vpu complex was found in the cytoplasm. Furthermore, neither Nef nor Vpu shows effect on the incorporation of Gag into viral particles. Conclusions The results showed that CD4 Nef complexes formed at the coated pits of cell surfaces, with or without expressing Vpu. Formation of CD4 Nef complexes could be important for the enhancement of CD4 down regulation.
2.Treating hyperhidrosis from liver and spleen
Mengzhen WANG ; Yue LUO ; Ziyu LIU ; Fengyi GUO ; Yuanping YIN ; Xiao YANG
Journal of Beijing University of Traditional Chinese Medicine 2024;47(4):490-495
Hyperhidrosis is a disease in which excessive sweat is secreted,resulting in an abnormal increase in systemic or local perspiration.In traditional Chinese medicine,hyperhidrosis belongs to the category of sweating disease.It is caused by an imbalance between yin and yang and abnormal excretion of body fluid.Many doctors treat the sweating disease from the perspective of heart,lung,and kidney;in contrast,we discuss the etiology and pathogenesis of hyperhidrosis from the perspective of liver and spleen,explain the significance of harmonizing the liver and spleen to improve the sweating disease,and put forward the key pathogenic factors of stagnation liver qi and spleen deficiency,and disharmony between nutrient qi and defensive qi,and the imbalance between yin and yang are the key pathogenic factor.Most of the clinical treatment start from the liver and spleen.The main treatment principle is based on soothing the liver and relieving depression,invigorating the spleen and nourishing blood,and regulating and harmonizing the nutrient qi and defensive qi,paying attention to the relationship between qi and blood in zangfu organs,invigorating the spleen and replenishing qi to consolidate its foundation,soothing the liver and relieving depression to regulate its qi,and invigorating qi and blood and perspiration.Treatment can be supplemented with Xiaoyao Powder plus-minus,mainly to strengthen liver wood and spleen soil,acquire nourishment,smooth qi,nourish the five zang,reconcile qi and blood,enhance physical strength and peace of mind,ensure sufficient qi to arrest sweating,coordinate the liver and spleen,balance the ascending and descending phases,and harmonize the five zang organs.
3.Results of combined therapy for 1260 patients with small cell lung cancer.
Dongfu CHEN ; Xiangru ZHANG ; Weibo YIN ; Yan SUN ; Yanjun MIAO ; Fengyi FENG ; Jinwan WANG ; Mei WANG ; Hongxing ZHANG ; Qinfu FENG ; Binghe XU ; Yuankai SHI
Chinese Journal of Oncology 2002;24(6):602-604
OBJECTIVETo evaluate the efficacy of combined modality treatment and determine the prognostic factors for small cell lung cancer (SCLC).
METHODSFrom January 1974 to December 1995, 1260 patients with SCLC treated were retrospectively evaluated, with limited lesions in 732 patients, extensive lesions in 500 and stage unrecorded in 28. 553 patients were alloted into chemotherapy + radiotherapy (C + R) group, 355 into C + R + C group, 97 into R + C group, 126 into C group, 64 into R group and 65 into surgery (S + C + R) group. Patients with limited lesions received 2 - 4 cycles of chemotherapy including COMC, COMP, COMVP and CE-CAP. Radiotherapy was given to a dose of 40 - 70 Gy/4 - 7 w. Radiation portals for patients with limited lesions encompassed the primary tumor, hilar lymphatic drainage areas, partial mediastinum and bilateral supraclavicular regions. Patients with extensive lesions mainly received chemotherapy with or without palliative irradiation.
RESULTSThe overall CR and PR rates were 26.7% and 52.3%. Local recurrence and distant metastasis rates were 58.8% and 61.5%. The 1-, 3- and 5-year survival rates were 50.2%, 14.7% and 11.7%, with median survival time of 12 months. The era, sex, age, tumor stage and treatment modality were all significant prognostic factors by both uni-variate and multi-variate analyses (P < 0.05). The result of S + C + R rated the best among these modalities and the result of C + R + C was superior to C + R, though the difference of which was not significant.
CONCLUSIONSurgical resection should be considered as one part of comprehensive therapy for small cell lung cancer patients with limited lesions whenever possible. On top of routine chemotherapy early administration of radiotherapy is advisable.
Adult ; Antineoplastic Combined Chemotherapy Protocols ; Carcinoma, Small Cell ; mortality ; therapy ; Combined Modality Therapy ; Female ; Humans ; Lung Neoplasms ; mortality ; therapy ; Male ; Middle Aged ; Radiotherapy ; Survival Rate ; Treatment Outcome